JPWO2022144911A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022144911A5
JPWO2022144911A5 JP2023533312A JP2023533312A JPWO2022144911A5 JP WO2022144911 A5 JPWO2022144911 A5 JP WO2022144911A5 JP 2023533312 A JP2023533312 A JP 2023533312A JP 2023533312 A JP2023533312 A JP 2023533312A JP WO2022144911 A5 JPWO2022144911 A5 JP WO2022144911A5
Authority
JP
Japan
Prior art keywords
anhydride
formula
substituted
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533312A
Other languages
Japanese (ja)
Other versions
JP2024501153A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2021/050262 external-priority patent/WO2022144911A1/en
Publication of JP2024501153A publication Critical patent/JP2024501153A/en
Publication of JPWO2022144911A5 publication Critical patent/JPWO2022144911A5/ja
Pending legal-status Critical Current

Links

Description

3-O,N-ビス-エトキシカルボニル-ノルモルフィン(2.00g、4.8mmol)の無水酢酸(11.34mL、120.0mmol)中撹拌溶液に、ジメチルスルホキシド(3.41mL、48.0mmol)を窒素の不活性雰囲気下で一度に添加し、得られた混合物を80℃で1.5時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(III)の化合物が検出された。次いで、トリエチルアミン(6.69mL、48.0mmol)を反応混合物に一度に添加し、80℃で2.5時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(IV)の化合物が検出された。反応混合物を室温に冷却し、水(50mL)で希釈し、シクロペンチルメチルエーテル(3×50mL)で抽出した。合わせた有機抽出物を飽和重炭酸ナトリウム水溶液(3×25mL)、水(25mL)で洗浄し、硫酸マグネシウムで乾燥させて真空中で濃縮すると、得られた表題化合物のHPLC分析により決定して96.27%の純度を有する表題化合物2.04g(理論値の93%)が残った。
実施例13a:ステップ3a:過酢酸を用いた式(VI)の化合物の調製:
3-O,N-ビス-エトキシカルボニル-14-ノルモルフィノン(R 及びR =エトキシカルボニルを有する化合物VI)
無水酢酸(15mL、120.0mmol)中の3-O,N-ビス-エトキシカルボニル-ノルモルフィンジエノールアセテート(5.0g、11.0mmol)の撹拌溶液に、50%H 水溶液(8.10mL、114mmol)を、不活性窒素雰囲気下で一度に添加し、得られた混合物を40℃で4時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(V)の化合物が検出された。反応混合物を室温に冷却し、水(50mL)で希釈し、2Mアンモニア水溶液(72mL)の添加により、pHをゆっくりと8まで調整した。混合物をクロロホルム(3×60mL)で抽出した。合わせた有機抽出物をブライン(75mL)で洗浄し、硫酸マグネシウムで乾燥させて真空中で濃縮すると、得られた表題化合物のHPLC分析により決定して92.31%の純度を有する表題化合物4.60g(理論値の98%)が残った。
To a stirred solution of 3-O,N-bis-ethoxycarbonyl-normorphine (2.00 g, 4.8 mmol) in acetic anhydride (11.34 mL, 120.0 mmol) was added dimethyl sulfoxide (3.41 mL, 48.0 mmol). was added in one portion under an inert atmosphere of nitrogen and the resulting mixture was stirred at 80° C. for 1.5 h, at which point <2% of the compound of formula (III) was detected in the reaction mixture by HPLC analysis. It was done. Triethylamine (6.69 mL, 48.0 mmol) was then added to the reaction mixture in one portion and stirred at 80° C. for 2.5 h, at which point there was <2% of formula (IV) in the reaction mixture by HPLC analysis. Compound detected. The reaction mixture was cooled to room temperature, diluted with water (50 mL), and extracted with cyclopentyl methyl ether (3 x 50 mL). The combined organic extracts were washed with saturated aqueous sodium bicarbonate (3 x 25 mL), water (25 mL), dried over magnesium sulfate and concentrated in vacuo to yield a 96% title compound as determined by HPLC analysis. 2.04 g (93% of theory) of the title compound remained with a purity of .27%.
Example 13a: Step 3a: Preparation of compound of formula (VI) using peracetic acid:
3-O,N-bis-ethoxycarbonyl-14-normorphinone (compound VI with R 1 and R 2 =ethoxycarbonyl)
To a stirred solution of 3-O,N-bis-ethoxycarbonyl-normorphine dienol acetate (5.0 g, 11.0 mmol) in acetic anhydride (15 mL, 120.0 mmol) was added 50% aqueous H 2 O ( 8 .10 mL, 114 mmol) was added in one portion under an inert nitrogen atmosphere and the resulting mixture was stirred at 40 °C for 4 h, at which point <2% of formula (V) was found in the reaction mixture by HPLC analysis. Compound detected. The reaction mixture was cooled to room temperature, diluted with water (50 mL), and the pH was slowly adjusted to 8 by addition of 2M aqueous ammonia (72 mL). The mixture was extracted with chloroform (3 x 60 mL). The combined organic extracts were washed with brine (75 mL), dried over magnesium sulfate and concentrated in vacuo to yield the title compound 4. with a purity of 92.31% as determined by HPLC analysis of the title compound. 60 g (98% of theory) remained.

Claims (17)

モルヒネからノルオキシモルフォンを調製するための方法であって、
Figure 2022144911000001

1)式(II)のモルヒネを反応させて式(III)の化合物を得るステップ、
2a)前記式(III)の化合物を酸化剤で酸化して式(IV)の化合物を得るステップ、
2b)前記式(IV)の化合物をアシル化剤でアシル化して式(V)の化合物を得るステップ、
3a)前記式(V)の化合物をペルオキシ酸化に供して式(VI)の化合物を得るステップ、
3b)前記式(VI)の化合物を還元して式(VII)の化合物を得るステップ、及び
4)前記式(VII)の化合物を加水分解して式(I)のノルオキシモルフォンを得るステップを含み、
式中、R及びRは、独立して1~20個の炭素原子を有する置換若しくは非置換アルキル基、又は置換若しくは非置換アリール基、又は1~20個の炭素原子を有する置換若しくは非置換アルキルアリール基、又は2~20個の炭素原子を有する置換若しくは非置換アルケニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルコキシカルボニル基、又は置換若しくは非置換アリールオキシカルボニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルアリールオキシカルボニル基、又はシアニド基、又は式Si(R(式中、基Rは同一又は異なっていてもよく、それぞれ1~6個の炭素原子を有する置換若しくは非置換アルキル基及び置換若しくは非置換アリール基からそれぞれ選択され、Rは、それぞれアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルカルボニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルアリールカルボニル基、又は置換若しくは非置換アリールカルボニル基、又は2~20個の炭素原子を有する置換若しくは非置換アルケニルカルボニル基である)のシリル基であり、
ステップ2aがAlbright-Goldman酸化条件を使用して行われ、
ステップ2a及びステップ2bをワンポット単一ステップ変換に組み合わせることができ、
ステップ3a及びステップ3bをワンポット単一ステップ変換に組み合わせることができる、方法。
A method for preparing noroxymorphone from morphine, comprising:
Figure 2022144911000001

1) reacting morphine of formula (II) to obtain a compound of formula (III);
2a) oxidizing the compound of formula (III) with an oxidizing agent to obtain a compound of formula (IV);
2b) acylating the compound of formula (IV) with an acylating agent to obtain a compound of formula (V);
3a) subjecting the compound of formula (V) to peroxyoxidation to obtain a compound of formula (VI);
3b) reducing the compound of formula (VI) to obtain a compound of formula (VII); and 4) hydrolyzing the compound of formula (VII) to obtain noroxymorphone of formula (I). including,
In the formula, R 1 and R 2 are independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, or a substituted or unsubstituted aryl group having 1 to 20 carbon atoms, or a substituted or unsubstituted aryl group having 1 to 20 carbon atoms. Substituted alkylaryl groups, or substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, or substituted or unsubstituted alkoxycarbonyl groups having 1 to 20 carbon atoms in the alkyl residue, or substituted or unsubstituted An aryloxycarbonyl group, or a substituted or unsubstituted alkylaryloxycarbonyl group having 1 to 20 carbon atoms in the alkyl residue, or a cyanide group, or a cyanide group, or a group of the formula Si(R 4 ) 3 (wherein the group R 4 is R 3 is selected from substituted or unsubstituted alkyl groups and substituted or unsubstituted aryl groups each having 1 to 6 carbon atoms, which may be the same or different, and each R 3 is selected from 1 to 20 carbon atoms in the alkyl residue. a substituted or unsubstituted alkylcarbonyl group having from 1 to 20 carbon atoms in the alkyl residue, or a substituted or unsubstituted arylcarbonyl group having from 1 to 20 carbon atoms in the alkyl residue; a substituted or unsubstituted alkenylcarbonyl group having 5 carbon atoms;
step 2a is performed using Albright-Goldman oxidation conditions;
Step 2a and step 2b can be combined into a one-pot single-step conversion,
A method in which step 3a and step 3b can be combined into a one-pot single-step conversion.
式(III)の化合物が、式(IV)の化合物を形成するために、Albright-Goldman酸化条件で典型的に利用される酸化剤を使用して酸化される、請求項1に記載の方法。 2. The method of claim 1, wherein the compound of formula (III) is oxidized to form the compound of formula (IV) using an oxidizing agent typically utilized in Albright-Goldman oxidation conditions. 前記酸化剤が、ジメチルスルホキシド(DMSO)及び非環式又は環式有機酸無水物である、請求項2に記載の方法。 3. The method of claim 2, wherein the oxidizing agent is dimethyl sulfoxide (DMSO) and an acyclic or cyclic organic acid anhydride. 前記酸無水物が、無水酢酸、安息香酸無水物、プロピオン酸無水物、ブタン酸無水物、ペンタン酸無水物、ヘキサン酸無水物、イソ酪酸無水物、イソ吉草酸無水物、アクリル酸無水物、メタクリル酸無水物、アンゲリカ酸無水物、クロトン酸無水物、ピバル酸無水物、トリフルオロ酢酸無水物、ジフルオロ酢酸無水物、モノフルオロ酢酸無水物、ペンタフルオロプロピオン酸無水物、クロロ酢酸無水物、無水コハク酸、無水マレイン酸、無水グルタル酸、無水アジピン酸、3-メチルグルタル酸無水物、3,3-ジメチルグルタル酸無水物、ヘキサフルオログルタル酸無水物、無水フタル酸、無水ホモフタル酸からなる群から選択される、請求項2及び3のいずれか一項に記載の方法。 The acid anhydride is acetic anhydride, benzoic anhydride, propionic anhydride, butanoic anhydride, pentanoic anhydride, hexanoic anhydride, isobutyric anhydride, isovaleric anhydride, acrylic anhydride, Methacrylic anhydride, angelic anhydride, crotonic anhydride, pivalic anhydride, trifluoroacetic anhydride, difluoroacetic anhydride, monofluoroacetic anhydride, pentafluoropropionic anhydride, chloroacetic anhydride, anhydride The group consisting of succinic acid, maleic anhydride, glutaric anhydride, adipic anhydride, 3-methylglutaric anhydride, 3,3-dimethylglutaric anhydride, hexafluoroglutaric anhydride, phthalic anhydride, homophthalic anhydride 4. A method according to any one of claims 2 and 3, selected from: ステップ2aにおける前記酸化反応が、大気圧及び約0℃~120℃の温度で適切に行われ得る、請求項1に記載の方法。 A method according to claim 1, wherein the oxidation reaction in step 2a may suitably be carried out at atmospheric pressure and at a temperature of about 0°C to 120°C. 前記酸化反応が55℃~65℃で行われる、請求項5に記載の方法。 A method according to claim 5, wherein the oxidation reaction is carried out at 55°C to 65°C. 前記アシル化剤が無水酢酸である、請求項3に記載の方法。 4. The method of claim 3, wherein the acylating agent is acetic anhydride. ステップ2bにおける前記アシル化が、酢酸ナトリウム又はトリエチルアミンの存在下で行われる、請求項1に記載の方法。 2. The method of claim 1, wherein the acylation in step 2b is carried out in the presence of sodium acetate or triethylamine. ステップ3aが、-10℃~100℃の温度の氷酢酸中で実質的に無水条件下で、予め形成された過ギ酸を用いて実施される、請求項1に記載の方法。 The method of claim 1, wherein step 3a is carried out using preformed performic acid under substantially anhydrous conditions in glacial acetic acid at a temperature of -10°C to 100°C. 前記過ギ酸が、ギ酸を30%以上の過酸化水素で処理することによって調製される、請求項9に記載の方法。 10. The method of claim 9, wherein the performic acid is prepared by treating formic acid with 30% or more hydrogen peroxide. ステップ3aが、-10℃~100℃の温度の氷酢酸中で、実質的に無水条件下で、過酢酸を用いて実施され、前記過酢酸は、予め形成され又はその場で生成されてもよい、請求項1に記載の方法。Step 3a is carried out with peracetic acid under substantially anhydrous conditions in glacial acetic acid at a temperature of -10°C to 100°C, said peracetic acid may be preformed or generated in situ. 2. The method of claim 1, wherein: ステップ3b)で使用される還元剤が10%パラジウム炭素である、請求項1に記載の方法。 2. The method of claim 1, wherein the reducing agent used in step 3b) is 10% palladium on carbon. 前記還元が、氷酢酸中25℃~80℃の温度範囲で行われる、請求項12に記載の方法。 A method according to claim 12 , wherein the reduction is carried out in glacial acetic acid at a temperature range of 25°C to 80°C. ステップ4における前記加水分解が、硫酸などの酸性加水分解触媒又は水酸化カリウムなどの塩基性加水分解触媒の存在下で行われる、請求項1に記載の方法。 2. The method of claim 1, wherein the hydrolysis in step 4 is carried out in the presence of an acidic hydrolysis catalyst such as sulfuric acid or a basic hydrolysis catalyst such as potassium hydroxide. 前記プロセスステップ2a、2b、3a及び3bが異なるポットで行われる、請求項1~14のいずれか一項に記載の方法。 15. A method according to any one of claims 1 to 14 , wherein the process steps 2a, 2b, 3a and 3b are carried out in different pots. 前記プロセスステップ1、2a、2b、3a、3b及び4が、バッチ反応器、又は連続フロー反応器、又はマイクロ波反応器、又はそれらの組み合わせで行われる、請求項1~15のいずれか一項に記載の方法。 16. Any one of claims 1 to 15 , wherein process steps 1, 2a, 2b, 3a, 3b and 4 are carried out in a batch reactor, or a continuous flow reactor, or a microwave reactor, or a combination thereof. The method described in. 前記R及びRがエトキシカルボニル基であり、Rがアセチル基である、請求項1~16のいずれか一項に記載の方法。 The method according to any one of claims 1 to 16 , wherein R 1 and R 2 are ethoxycarbonyl groups and R 3 is an acetyl group.
JP2023533312A 2020-12-28 2021-03-15 A novel method for the synthesis of noroxymorphone from morphine Pending JP2024501153A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202021056621 2020-12-28
IN202021056621 2020-12-28
PCT/IN2021/050262 WO2022144911A1 (en) 2020-12-28 2021-03-15 Novel process for the synthesis of noroxymorphone from morphine

Publications (2)

Publication Number Publication Date
JP2024501153A JP2024501153A (en) 2024-01-11
JPWO2022144911A5 true JPWO2022144911A5 (en) 2024-03-04

Family

ID=82260596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533312A Pending JP2024501153A (en) 2020-12-28 2021-03-15 A novel method for the synthesis of noroxymorphone from morphine

Country Status (8)

Country Link
US (1) US20230357257A1 (en)
EP (1) EP4267583A1 (en)
JP (1) JP2024501153A (en)
KR (1) KR20230127222A9 (en)
AU (1) AU2021416361A1 (en)
BR (1) BR112023012708A2 (en)
CA (1) CA3200832A1 (en)
WO (1) WO2022144911A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562072B1 (en) * 1984-03-27 1989-07-07 Mallinckrodt Inc PROCESS FOR THE PREPARATION OF NOROXYMORPHONE FROM MORPHINE, AND INTERMEDIATE COMPOUNDS USED IN THIS PROCESS
EP2829541A1 (en) * 2013-07-26 2015-01-28 Siegfried AG Novel synthesis of noroxymorphone from morphine

Similar Documents

Publication Publication Date Title
CN103880903B (en) A kind of preparation method of tylosin class macrolide and derivant thereof
US4425273A (en) Process for production of chenodeoxycholic acid
CN108503531B (en) Preparation method of 3, 3-dimethyl-2-oxobutyric acid
Kitamura et al. Pd (II)-catalyzed formal O–H insertion reactions of diazonaphthoquinones to acetic acid: synthesis of 1, 2-naphthalenediol derivatives
CN113698331A (en) Synthetic method of L-selenium-methyl selenocysteine
JP4327248B2 (en) New derivatives of 5-O-deosaminyl-6-O-methylerythronolide A, processes for their preparation and their use in the production of biologically active substances
WO2008069440A1 (en) The preparation method of 2-de0xy-l-rib0se
EP1765848B8 (en) Process for the preparation of 4-azasteroids
JPH0150704B2 (en)
US8039626B2 (en) Method of manufacturing of 7-ethyl-10-hydroxycamptothecin
JPWO2022144911A5 (en)
EP1503983B1 (en) A process for the preparation of modafinil
EP0003643A1 (en) Process for the preparation of 4-(6-methoxy-2-naphthyl)-butan-2-one; 4-(6-methoxy-2-naphthyl)-4-hydroxybut-3-en-2-one and a process for its preparation
EP1940770B1 (en) Novel method for preparing unsaturated fatty hydroxyacids
JPH049349A (en) Production of 3-phenoxypropanal compound
JP2024501153A (en) A novel method for the synthesis of noroxymorphone from morphine
Lee et al. A practical and stereoselective synthesis of cinnamyl alcohols bearing α-cyano or α-ester functional group from Baylis-Hillman adducts
JP2001011026A (en) Production of 3-methyl-4-nitrobenzoic acid
US5405978A (en) Oxidative preparation of 3,5-secoandrost-5-one-3,17 β-dioic acid
JPH0124782B2 (en)
JP3063175B2 (en) Method for producing 4-hydroxycyclopentenones
KR100271294B1 (en) Process for the preparation of 2-[(2,6-dichlorophenyl)amino]phenylacetoxy acetic acid
KR20220168271A (en) Novel preparing method for regioselective 1,5-dimethyltetrazole
KR100470975B1 (en) Efficient methods for preparing agi-7 and sescandelin
CA1066291A (en) 3-formyl-4-methyl-2,6-dihydroxypyridine and a process for its preparation